Navigation Links
Zimmer Holdings to Present at UBS Best of Americas Conference 2013
Date:8/20/2013

WARSAW, Ind., Aug. 20, 2013 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH), a global leader in musculoskeletal care, announced that it will be participating in the UBS Best of Americas Conference 2013 at the UBS London offices, 1 Finsbury Avenue, London, EC2M 2PP, on September 12, 2013, at 9:30 a.m. Greenwich Mean Time.

A live webcast of the presentation can be accessed via Zimmer's Investor Relations website at http://investor.zimmer.com.  The webcast will be archived for replay following the conference.

About the Company

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products.  Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries.  Zimmer's 2012 sales were approximately $4.5 billion.  The Company is supported by the efforts of more than 9,000 employees worldwide.

Zimmer Safe Harbor Statement

This press release contains forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 based on current expectations, estimates, forecasts and projections about the orthopaedics industry, management's beliefs and assumptions made by management.  Forward-looking statements may be identified by the use of forward-looking terms such as "may," "will," "expects," "believes," "anticipates," "plans," "estimates," "projects," "assumes," "guides," "targets," "forecasts," and "seeks" or the negative of such terms or other variations on such terms or comparable terminology.  These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that could cause actual outcomes and results to differ materially.  For a list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission.  We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be set forth in our periodic reports.  Readers of this document are cautioned not to place undue reliance on these forward-looking statements, since, while we believe the assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements will prove to be accurate.  This cautionary statement is applicable to all forward-looking statements contained in this document.

 


'/>"/>
SOURCE Zimmer Holdings, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Zimmer Holdings to Present at the Bank of America Merrill Lynch 2013 Healthcare Conference
2. UPDATE: Zimmer Holdings Announces Live Audio Webcast and Conference Call of Second Quarter 2013 Results
3. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Second Quarter 2013 Results
4. Zimmer Announces Distribution Of APEX Spine System
5. FDA Approvals, Diversified Product Pipeline, Produce Sales Growth, and Positive Study Outcomes - Research Report on Boston Scientific, Zimmer, St. Jude, ResMed, and GenMark
6. Zimmer Announces Quarterly Dividend for Second Quarter of 2013
7. Zimmer Acquires NORMED Medizin-Technik GmbH
8. Zimmer Holdings to Present at Deutsche Bank Securities Annual Health Care Conference
9. Zimmer Acquires Knee Creations, LLCs Business
10. Zimmer Holdings, Inc. Reports First Quarter 2013 Financial Results
11. Zimmer Holdings Announces Live Audio Webcast and Conference Call of First Quarter 2013 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... 2016 Yissum Research Development ... today that it had signed an exclusive world-wide licensing ... of novel protein degradation and immunomodulatory drugs for cancer ... drug candidates representing first-in-class therapy for hematologic and solid ... The novel technology was developed by ...
(Date:5/4/2016)... , May 4, 2016 ... addition of the  "Global Acute Myeloid Leukemia ...  report to their offering.       ... Acute Myeloid Leukemia Market and Competitive Landscape ... Myeloid Leukemia pipeline products, Acute Myeloid Leukemia ...
(Date:5/3/2016)... -- Research and Markets has announced the ... Market Outlook 2020" report to their offering. ... technology has improved significantly in past years due to ... coming years. Many cancer drugs have been developed by ... also expected to be developed with its help. They ...
Breaking Medicine Technology:
(Date:5/5/2016)... ... May 05, 2016 , ... A local ... that more than 40 percent of participating fifth-grade students already have or are ... and Asthma Clinical Research in the Division of Pulmonary, Allergy and Critical Care ...
(Date:5/5/2016)... (PRWEB) , ... May 05, 2016 , ... Dr. Benjamin ... in non-surgical hair loss treatment. Dr. Stong is double board certified and the ... for the treatment of hair loss. Non-surgical therapies such as stem cells can ...
(Date:5/5/2016)... , ... May 05, 2016 , ... The 2016 Nike ... Derek Pittman, along with his university coaching staff. Together they bring their winning Vandals ... sessions run for youth players ages 5-13, and high school players. Session dates are ...
(Date:5/5/2016)... ... May 05, 2016 , ... When stiff and achy ... alleviate the pain that’s a common osteoarthritis (OA) symptom. Yet, numerous clinical studies ... with arthritis. , “Physical therapy exercises are commonly prescribed to individuals with ...
(Date:5/5/2016)... ... May 05, 2016 , ... The Lung Institute will celebrate its three-year ... seminar at most clinic locations throughout the month of May. To date, the Lung Institute ... rapid growth that we’ve seen is a testament to the success of this treatment and ...
Breaking Medicine News(10 mins):